$30.86
0.13% yesterday
NYSE, Sep 02, 10:00 pm CET
ISIN
US1940141062
Symbol
ENOV

Colfax Corporation Stock price

$30.84
+4.21 15.81% 1M
-7.02 18.54% 6M
-13.04 29.72% YTD
-15.76 33.82% 1Y
-18.15 37.05% 3Y
-104.80 77.26% 5Y
-117.20 79.17% 10Y
-53.16 63.29% 20Y
NYSE, Closing price Tue, Sep 02 2025
-0.06 0.19%
ISIN
US1940141062
Symbol
ENOV

Key metrics

Basic
Market capitalization
$1.8b
Enterprise Value
$3.1b
Net debt
$1.3b
Cash
$44.1m
Shares outstanding
57.2m
Valuation (TTM | estimate)
P/E
negative | 9.7
P/S
0.8 | 0.8
EV/Sales
1.4 | 1.4
EV/FCF
negative
P/B
0.7
Financial Health
Equity Ratio
54.3%
Return on Equity
-32.2%
ROCE
-0.1%
ROIC
-0.1%
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$2.2b | $2.3b
EBITDA
$162.8m | $395.5m
EBIT
$-5.7m | $271.5m
Net Income
$-827.6m | $182.2m
Free Cash Flow
$-4.0m
Growth (TTM | estimate)
Revenue
14.4% | 9.1%
EBITDA
0.8% | 13.0%
EBIT
-155.2% | 2,117.8%
Net Income
-813.9% | 122.1%
Free Cash Flow
93.5%
Margin (TTM | estimate)
Gross
56.3%
EBITDA
7.4% | 17.2%
EBIT
-0.3%
Net
-37.8% | 7.9%
Free Cash Flow
-0.2%
More
EPS
$-14.5
FCF per Share
$-0.1
Short interest
17.5%
Employees
7k
Rev per Employee
$290.0k
Show more

Is Colfax Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Colfax Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Colfax Corporation forecast:

15x Buy
88%
2x Hold
12%

Analyst Opinions

17 Analysts have issued a Colfax Corporation forecast:

Buy
88%
Hold
12%

Financial data from Colfax Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jul '25
+/-
%
2,190 2,190
14% 14%
100%
- Direct Costs 956 956
17% 17%
44%
1,233 1,233
12% 12%
56%
- Selling and Administrative Expenses 967 967
14% 14%
44%
- Research and Development Expense 104 104
22% 22%
5%
163 163
1% 1%
7%
- Depreciation and Amortization 168 168
11% 11%
8%
EBIT (Operating Income) EBIT -5.69 -5.69
155% 155%
0%
Net Profit -828 -828
814% 814%
-38%

In millions USD.

Don't miss a Thing! We will send you all news about Colfax Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Colfax Corporation Stock News

Neutral
Seeking Alpha
7 days ago
Enovis remains out of favor despite solid results, but I still see potential for mid-single-digit revenue growth and low double-digit FCF margins long-term. The Recon business is performing well, gaining share in extremities, while P&R remains a slow-growth drag on overall performance and valuation. Tariff risks are manageable, but I'm unimpressed by the new CEO's lack of ortho experience.
Neutral
GlobeNewsWire
26 days ago
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
Neutral
Seeking Alpha
26 days ago
Enovis Corporation (NYSE:ENOV ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Damien McDonald - CEO & Director Kyle William Rose - Vice President of Investor Relations Phillip Benjamin Berry - Senior VP & CFO Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Dane M. Reinhardt - Robert W.
More Colfax Corporation News

Company Profile

Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.

Head office United States
CEO Damien McDonald
Employees 7,367
Founded 1995
Website www.enovis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today